DIATHEVA - Biomanufacturing of innovative diagnostics and reagents

Thursday, 09 June 2016 15:31

BIO 2016 : DIATHEVA presents "scFv 2G8" monoclonal antibody a new approach to fungal infections

Inmi Tweet Inmi Tweet

DIATHEVA presented a new product in pipeline "scFv 2G8" at BIO CONVENTION 2016 in the context of a workshop dedicated to showcasing of novel antibiotics which was held the past 6 June in San Francisco. Hosted by the Innovative Medicines’ Initiative (IMI), The Wellcome Trust-funded Community For Open Antimicrobial Drug Discovery and the IMI funded ENABLE project, the workshop was aimed to highlight the global tools available to support the development of novel anti-infectives coming from10 innovative company programmes from six countries.


DIATHEVA the unique Italian company selected presented a new scFv monoclonal antibody 2G8 in the therapeutic area of infectious disease.

Company certified
Certified N.
Phone (+39) 0721 830605
Fax (+39) 0721 837154
website netcompany

By navigating this website you provide your agreement to the use of cookies, which we use to improve your navigation experience and for statistical analysis. Read our Cookie Policy to learn more

Your Shopping Cart

Cart empty